Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 8127.77x is in line with its estimated 1-year average of 8683.24x, near the low end of its estimated 1-year range (7424.75x–9947.01x).
As of 2026-10-06T13:30:58.219Z.
Calculation as of: 2026-10-06T13:30:58.219Z.
Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 9f8c720c17565e189db9218018d8859aabec9e8167d5f057fd0cc602bb9808d0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
8127.77x
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
15.37x
median of 161 covered companies
CURRENT VS SECTOR MEDIAN
+52780.74%
vs the sector median at left
Market Cap
$484.56M
EV/EBITDA Ratio
N/A
TTM Avg
5.88x
3Y Avg
17.52x
5Y Avg
17.52x
Market Cap
$488.09M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$514.16M
EV/EBITDA Ratio
N/A
TTM Avg
74.72x
3Y Avg
37.71x
5Y Avg
26.88x
Market Cap
$458.01M
EV/EBITDA Ratio
N/A
TTM Avg
81.39x
3Y Avg
32.05x
5Y Avg
24.98x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cerus Corporation (CERS) | $477.61M | 8127.77x | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $483.26M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $484.56M | N/A | 5.88x | 17.52x | 17.52x |
| NRC Health (NRC)vs › | $470.12M | 23.83x | 16.39x | 15.03x | 16.69x |
| Bright Minds Biosciences Inc. (DRUG)vs › | $488.09M | N/A | N/A | N/A | N/A |
| NeoGenomics, Inc. (NEO)vs › | $514.16M | N/A | 74.72x | 37.71x | 26.88x |
| Evolus, Inc. (EOLS)vs › | $491.93M | N/A | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $465.02M | 10.37x | 9.91x | 9.78x | 16.95x |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $458.01M | N/A | 81.39x | 32.05x | 24.98x |
| Assembly Biosciences, Inc. (ASMB)vs › | $452.63M | N/A | N/A | N/A | N/A |
At 8127.8, EV/EBITDA is at an extreme level, where the multiple carries little signal — higher than 22% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
7424.8
median
8731.5
estimated 1-year high
9947.0
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-10-05 | 8002.14x |
| 2026-10-02 | 7819.81x |
| 2026-10-01 | 7941.36x |
| 2026-09-30 | 8123.69x |
| 2026-09-29 | 8397.19x |
| 2026-09-28 | 8336.41x |
| 2026-09-25 | 8853.02x |
| 2026-09-24 | 8822.63x |
| 2026-09-23 | 8792.24x |
| 2026-09-22 | 9004.96x |
| 2026-09-21 | 8670.69x |
| 2026-09-18 | 8944.19x |
| 2026-09-17 | 8974.57x |
| 2026-09-16 | 8579.52x |
| 2026-09-15 | 8488.36x |
| 2026-09-14 | 8640.30x |
| 2026-09-11 | 8457.97x |
| 2026-09-10 | 8366.80x |
| 2026-09-09 | 8518.74x |
| 2026-09-08 | 8609.91x |
| 2026-09-04 | 8761.85x |
| 2026-09-03 | 8701.08x |
| 2026-09-02 | 8792.24x |
| 2026-09-01 | 8822.63x |
| 2026-08-31 | 8913.80x |
| 2026-08-28 | 8944.19x |
| 2026-08-27 | 9156.91x |
| 2026-08-26 | 9217.68x |
| 2026-08-25 | 9156.91x |
| 2026-08-24 | 9065.74x |
| 2026-08-21 | 9430.40x |
| 2026-08-20 | 9369.63x |
| 2026-08-19 | 9551.96x |
| 2026-08-18 | 9278.46x |
| 2026-08-17 | 9916.62x |
| 2026-08-14 | 9947.01x |
| 2026-08-13 | 9521.57x |
| 2026-08-12 | 9126.52x |
| 2026-08-11 | 8701.08x |
| 2026-08-10 | 8549.13x |
| 2026-08-07 | 8032.53x |
| 2026-08-06 | 7941.36x |
| 2026-08-05 | 7789.42x |
| 2026-08-04 | 7546.31x |
| 2026-08-03 | 7424.75x |
| 2026-07-31 | 7424.75x |